Crossmark

Economic cost of long-term albumin treatment in cirrhotic patients with uncomplicated ascites based on the ANSWER trial: The Spanish healthcare system perspective

Crossref DOI link: https://doi.org/10.1016/j.medcli.2025.107154

Published Print: 2025-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Fernández, Javier

Coll-Ortega, Cristina

Fuster, Cristina

Davis, Anne

Simó, Pablo

Aceituno, Susana

Soler, Maria
Funding

Funding for this research was provided by:

Grifols SA
License Information

Text and Data Mining valid from 2025-11-01

Text and Data Mining valid from 2025-11-01

Version of Record valid from 2025-07-31
More Information

This article is maintained by: Elsevier

Article Title: Economic cost of long-term albumin treatment in cirrhotic patients with uncomplicated ascites based on the ANSWER trial: The Spanish healthcare system perspective

Journal Title: Medicina Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcli.2025.107154

Content Type: article

Copyright: © 2025 The Authors. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below